API
< Back to all clusters
[BUSINESS] · United Kingdom · 2 sources

started · updated

Codis expands pharmaceutical spray drying capacity in Haverhill

Codis has completed demolition work at its Haverhill, UK, site to begin construction on an expansion project. The development will house a new GEA Pharma-SD PSD-4 solvent-capable spray dryer, aimed at increasing commercial-scale production of amorphous solid dispersions (ASDs).

ASDs are a formulation technology used to improve the bioavailability and absorption of poorly soluble drug candidates. The new capacity is intended to help pharmaceutical companies transition promising compounds from early development into large-scale manufacturing.

The project will utilize the existing 100,000-square-foot cGMP facility and its established infrastructure. This expansion is designed to complement Codis’ existing capabilities in Nottingham, creating a more integrated pathway for programs moving from formulation development and analytical services to commercial-scale spray drying. The dryer's Factory Acceptance Test is scheduled for November, with the additional capacity expected to be available in the fourth quarter of 2027.

Entities

Codis · GEA Pharma-SD · Haverhill · Nick Hodgson · Nottingham